
|Articles|January 20, 2005
Hormone therapy significantly increases risk of bone fractures
The risk of bone fractures increases for those prostate cancer patients on androgen-deprivation therapy by more than 40%, according an article in last week's New England Journal of Medicine (2005; 352:154-64).
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
FDA approves lutetium Lu 177 vipivotide tetraxetan for PSMA-positive mHSPC
2
Individualizing androgen pathway therapy in mCSPC
3
Testosterone deficiency: FAQs from the AUA guideline
4
Cretostimogene Grenadenorepvec: Mechanism and Rationale
5












